Furthermore, we speculated and detected several key transcription factors as the potential regulatory effects in lipid metabolic disorders, PPARα, PPARγ, and SREBP1, and found their aberrant expression in the PM2.5 exposure group. The gene discussed is SREBF1; the disease is Disorder of lipid metabolism.